Carrie Brownstein
Director/Board Member at SHATTUCK LABS, INC.
Net worth: 1 M $ as of 2024-05-30
Carrie Brownstein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHATTUCK LABS, INC. | Director/Board Member | 2021-10-21 | - |
| Independent Dir/Board Member | 2021-10-21 | - |
Career history of Carrie Brownstein
Former positions of Carrie Brownstein
| Companies | Position | Start | End |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-02 | 2024-01-18 |
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 2020-04-12 | 2022-09-27 |
| CELGENE | Chief Tech/Sci/R&D Officer | 2017-02-28 | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 2012-07-31 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Training of Carrie Brownstein
| Tufts University School of Medicine | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistics
International
| United States | 8 |
| France | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Stock Market
- Insiders
- Carrie Brownstein
- Experience
